You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 8, August 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics of Head & Neck Disease
 •Hearing Loss/ Deafness
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic

Polyethylenimine-Mediated Cochlear Gene Transfer in Guinea Pigs

Brian Tiong Gee Tan, BEng; Kok Heng Foong, BS; Myranda Mui Gek Lee, BApplSc; Runsheng Ruan, MB, MD

Arch Otolaryngol Head Neck Surg. 2008;134(8):884-891.

Objective  To demonstrate and compare polycationic-mediated cochlear gene transfer with linear polyethylenimine (PEI) via cochleostomy and osmotic pump infusion method.

Design  A dissociated cochlear culture was used to select the optimum nitrogen to phosphate ratio of PEI/DNA complexes to be used in vivo. The PEI–enhanced green fluorescent protein reporter gene DNA complex was introduced with single inoculation (cochleostomy) or with sustained delivery (osmotic pump method) into guinea pig cochleas and examined for transgene expression.

Subjects  Male Albino Hartley guinea pigs (250-350 g).

Results  The relatively low transfection efficiency of PEI limits its potential when compared with viral counterparts; however, sustained release of the vector solution was able to improve PEI's transfection efficiency. The PEI-infused cochleas maintained intact cellular and tissue architecture with absence of inflammation. Transfection confined to the perilymphatic space highlights the need to target the gene vector into the scala media if transfection is targeted at cells within the organ of Corti.

Conclusion  These findings indicate that PEI is able to transfect the cochlea in vivo with sustained delivery and present an alternative for nonviral cochlear gene therapy.


Author Affiliations: Delivery of Drugs, Proteins and Genes Group, Institute of Bioengineering and Nanotechnology, Singapore, Singapore (Mr Tan, Ms Lee, and Dr Ruan); School of Biological Sciences, Nanyang Technological University, Singapore (Mr Tan); and Department of Otolaryngology, National University of Singapore (Mr Foong and Dr Ruan).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.